TABITHA DAVIS: Open Payments
NPI 1700532967 · IRVINGTON, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$100 in 6 payments from 5 companies in 2025. Trend: 2023 $36 · 2024 $73 · 2025 $100
Food & beverage: $100
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $36 |
| AstraZeneca Pharmaceuticals LP | 1 | $17 |
| Novartis Pharmaceuticals Corporation | 1 | $16 |
| ABBVIE INC. | 1 | $16 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $14 |
Products named: Kerendia, LEQVIO, VRAYLAR, CAPLYTA.
Industry payments across KY — which companies pay providers there.
